Tower Research Capital (TRC)’s Dermata Therapeutics DRMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11K | Buy |
532
+352
| +196% | +$2.06K | ﹤0.01% | 4548 |
|
|
2025
Q1 | $1.94K | Buy |
180
+41
| +29% | +$442 | ﹤0.01% | 4624 |
|
|
2024
Q4 | $1.88K | Sell |
139
-150
| -52% | -$2.03K | ﹤0.01% | 4942 |
|
|
2024
Q3 | $4.74K | Buy |
289
+116
| +67% | +$1.9K | ﹤0.01% | 4434 |
|
|
2024
Q2 | $4.14K | Buy |
173
+135
| +355% | +$3.23K | ﹤0.01% | 4813 |
|
|
2024
Q1 | $2.36K | Sell |
38
-5
| -12% | -$310 | ﹤0.01% | 5061 |
|
|
2023
Q4 | $3.92K | Buy |
43
+9
| +26% | +$820 | ﹤0.01% | 5028 |
|
|
2023
Q3 | $5.45K | Sell |
34
-4
| -11% | -$641 | ﹤0.01% | 4718 |
|
|
2023
Q2 | $9.38K | Sell |
38
-1
| -3% | -$247 | ﹤0.01% | 4272 |
|
|
2023
Q1 | $7K | Buy |
39
+37
| +1,850% | +$6.64K | ﹤0.01% | 4731 |
|
|
2022
Q4 | $2K | Hold |
2
| – | – | ﹤0.01% | 5349 |
|
|
2022
Q3 | $2K | Hold |
2
| – | – | ﹤0.01% | 5545 |
|
|
2022
Q2 | $3K | Buy |
2
+1
| +100% | +$1.5K | ﹤0.01% | 5362 |
|
|
2022
Q1 | $3K | Hold |
1
| – | – | ﹤0.01% | 5357 |
|
|
2021
Q4 | $3K | Sell |
1
-1
| -50% | -$3K | ﹤0.01% | 5431 |
|
|
2021
Q3 | $21K | Buy |
+2
| New | +$21K | ﹤0.01% | 3661 |
|